Factors Associated with Symptom-to-Door Delay in Patients with ST-Segment Myocardial Infarction: A Systematic Review

Prehosp Disaster Med. 2023 Aug;38(4):485-494. doi: 10.1017/S1049023X23006039. Epub 2023 Jul 24.

Abstract

Background: Decreasing symptom-to-door (S2D) delay is of vital importance for reducing morbidity and mortality in patients with ST-segment elevation myocardial infarction (STEMI). The factors associated with S2D delay in STEMI patients have not been well-characterized.

Objectives: The aim of this study was to identify factors associated with S2D delay in patients with STEMI.

Methods: The PubMed, CINAHL, and Embase databases were searched for data. References from the selected articles and relevant background papers were also manually searched to identify additional eligible studies. The included articles were reviewed and assessed for risk of bias. The level of evidence for each identified factor was evaluated using a semiquantitative synthesis.

Results: Twelve (12) papers were included in the review. Factors associated with S2D delay were complex and could be divided into sociodemographic, clinical history, and onset characteristics. The level of evidence regarding female sex and diabetes was strong, and the evidence was moderate regarding older age, smoking, history of hypertension, self-transport, or referral.

Conclusions: Female sex, older age, previous diabetes, previous hypertension, smoking, and self-transport are all strong or moderate risk factors for S2D time delay in patients with ST-segment myocardial infarction. More efforts should be made to educate at-risk populations concerning symptoms of STEMI and the importance of seeking early medical assistance.

Keywords: Emergency Medical Services; ST-segment myocardial infarction; prehospital delay; symptom-to-door delay; systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Delivery of Health Care
  • Humans
  • Patient Acceptance of Health Care
  • Risk Factors
  • ST Elevation Myocardial Infarction* / therapy
  • Time-to-Treatment*
  • Treatment Delay